Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Harvard Business School
Dow
AstraZeneca
Merck

Last Updated: February 3, 2023

Setmelanotide acetate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic sources for setmelanotide acetate and what is the scope of freedom to operate?

Setmelanotide acetate is the generic ingredient in one branded drug marketed by Rhythm and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Setmelanotide acetate has eighty-seven patent family members in twenty countries.

One supplier is listed for this compound.

Summary for setmelanotide acetate
International Patents:87
US Patents:3
Tradenames:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 19
Patent Applications: 121
DailyMed Link:setmelanotide acetate at DailyMed
Pharmacology for setmelanotide acetate

US Patents and Regulatory Information for setmelanotide acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rhythm IMCIVREE setmelanotide acetate SOLUTION;SUBCUTANEOUS 213793-001 Nov 25, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing Y Y See Plans and Pricing
Rhythm IMCIVREE setmelanotide acetate SOLUTION;SUBCUTANEOUS 213793-001 Nov 25, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing Y Y See Plans and Pricing
Rhythm IMCIVREE setmelanotide acetate SOLUTION;SUBCUTANEOUS 213793-001 Nov 25, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Rhythm IMCIVREE setmelanotide acetate SOLUTION;SUBCUTANEOUS 213793-001 Nov 25, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Rhythm IMCIVREE setmelanotide acetate SOLUTION;SUBCUTANEOUS 213793-001 Nov 25, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Rhythm IMCIVREE setmelanotide acetate SOLUTION;SUBCUTANEOUS 213793-001 Nov 25, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for setmelanotide acetate

Country Patent Number Title Estimated Expiration
Israel 288961 תכשירים רוקחיים (Pharmaceutical compositions) See Plans and Pricing
Portugal 2286825 See Plans and Pricing
Singapore 163585 MELANOCORTIN RECEPTOR LIGANDS See Plans and Pricing
Denmark 2236151 See Plans and Pricing
South Korea 20160020405 약학적 조성물 (PHARMACEUTICAL COMPOSITIONS) See Plans and Pricing
Israel 241378 תכשירים רוקחיים (Pharmaceutical compositions) See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for setmelanotide acetate

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2970389 CA 2021 00054 Denmark See Plans and Pricing PRODUCT NAME: SETMELANOTID ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/21/1564 20210719
2236151 301150 Netherlands See Plans and Pricing PRODUCT NAME: SETMELANOTIDE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/21/1564 20210719
2236151 21C1060 France See Plans and Pricing PRODUCT NAME: SETMELANOTIDE OU L'UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE: EU/1/21/1564 20210719
2970389 2021C/551 Belgium See Plans and Pricing PRODUCT NAME: SETMELANOTIDE, ALSMEDE DOOR HET BASISOCTROOI BESCHERMDE, THERAPEUTISCH EQUIVALENTE AFGELEIDEN ERVAN; AUTHORISATION NUMBER AND DATE: EU/1/21/1564 20210719
2236151 52/2021 Austria See Plans and Pricing PRODUCT NAME: SETMELANOTID; REGISTRATION NO/DATE: EU/1/21/1564 (MITTEILUNG) 20210719
2236151 122021000084 Germany See Plans and Pricing PRODUCT NAME: SETMELANOTID; REGISTRATION NO/DATE: EU/1/21/1564 20210716
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Baxter
Merck
McKinsey
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.